InnoCare to Present at the 42nd Annual J.P. Morgan Healthcare Conference


Beijing, Dec. 28, 2023 – InnoCare Pharma (HKEX: 09969; SSE: 688428) announced today that Dr. Jasmine Cui, Co-founder, Chairwoman and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference, at 08:30 AM, January 10, 2024, U.S. Pacific Standard Time (00:30 AM, January 11, 2023, Beijing Time), to update the Company’s latest development.

The J.P. Morgan Healthcare Conference is the most influential event for the global pharma industry and the investment community. The 42nd Conference will be held in San Francisco, the United States, on January 8-11, 2024.


January 10, 08:30 AM - 08:55 AM, PST

January 11, 00:30 AM - 00:55 AM, Beijing Time


Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare

Webcast link:

During the Conference, we warmly welcome to have in-depth talks with our executives.

画板 1 拷贝.jpg

About InnoCare

InnoCare is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases with unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, Hong Kong, and United States.